Compare CVS Health Corp (CVS) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Nvidia Corp — how do they compare? CVS Health Corp trades at $107.56 (market cap $135.48B), while Nvidia Corp trades at $208.57 (market cap $5.13T). The key difference: Nvidia Corp is far larger — about 37.9× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.51%). Which is the better fit depends on your goals.
| CVS | NVDA | |
|---|---|---|
Market Cap | $135.48B | $5.13T |
Sector | Health | Technology |
52-Week High | $106.18 | $235.75 |
52-Week Low | $58.75 | $165.17 |
Enterprise Value | $202.02B | $5.06T |
Dividend Yield | 2.51% | 0.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
NVIDIA (NVDA) trades at $210.16, up 3.26% today, reflecting strong momentum amid bullish technical signals and robust fundamentals. The stock exhibits a P/E of 32.43 and a net income margin of 62.97%, with revenue surging to $130.50B in 2025. Recent earnings beats and a consensus analyst price target of $325.86 underscore confidence in its AI leadership and growth trajectory.
Outlook remains positive given accelerating AI demand and earnings strength, though risks include heightened valuations, competitive pressures, and market volatility. The stock presents a compelling growth opportunity for investors aligned with long-term AI trends, supported by solid cash flows and institutional bullishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
